Basile, M., Rumi, F. and Cicchetti, A. 2021. Budget Impact analysis of ponatinib for the management of patients with chronic myeloid leukemia. Global and Regional Health Technology Assessment. 8, 1 (Jul. 2021), 87–95. DOI:https://doi.org/10.33393/grhta.2021.2238.